DCM Shriram Ltd.
DCMSHRIRAMDiversified filings
We hold this company’s filings and have not read the financial statements out of them yet. Every filing on record is listed under filings, and each one opens.
Earnings calls
17 transcript(s)/analyst meet(s) served; 0 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 17 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| TRANSCRIPT | 20220513 | 2022-03-31 | yes | |
| TRANSCRIPT | 20220730 | 2022-06-30 | yes | |
| TRANSCRIPT | 20221025 | 2022-09-30 | yes | |
| TRANSCRIPT | 20230512 | 2023-03-31 | yes | |
| TRANSCRIPT | 20230802 | 2023-06-30 | yes | |
| TRANSCRIPT | 20231108 | 2023-09-30 | yes | |
| TRANSCRIPT | 20240208 | 2023-12-31 | yes | |
| TRANSCRIPT | 20240513 | 2024-03-31 | yes | |
| TRANSCRIPT | 20240731 | 2024-06-30 | yes | |
| TRANSCRIPT | 20241111 | 2024-09-30 | yes | |
| TRANSCRIPT | 20250127 | 2024-12-31 | yes | |
| TRANSCRIPT | 20250514 | 2025-03-31 | yes | |
| TRANSCRIPT | 20250729 | 2025-06-30 | yes | |
| TRANSCRIPT | 20251106 | 2025-09-30 | yes | |
| TRANSCRIPT | 20260129 | 2025-12-31 | yes | |
| TRANSCRIPT | 20260521 | 2026-03-31 | yes | |
| TRANSCRIPT | 20260805 | 2026-06-30 | yes |
DCMSHRIRAM
files the standard Schedule III statements. Every figure below opens to the filing it was read from; where a figure is not shown, the reason is printed in its place.
Identity
| Statement division | general |
| Scope served | consolidated |
| Panels on this page | 4 |
Market
No split, bonus or consolidation is on record for this company inside the period this price series covers, so the closes need no adjustment.
| Last close | 975.60 |
| 52-week range | 964.0 – 1330.2 |
| Return 1M | -7.34% |
| Return 3M | -6.69% |
| Return 1Y | -18.09% |
| Return 3Y | -8.16% |
| Return 5Y | -4.65% |
| Market capitalisation | not shown — we could not confirm it |
| Shares outstanding | not shown — we could not confirm it |
| P/E | not shown — we could not confirm it |
| P/B | not shown — we could not confirm it |
| EV/EBITDA | not shown — we could not confirm it |
Latest quarter filed — period ending 2026-06-30
In INR crore except per-share figures. `period_id` is the period the filing names for the number; the date beside each cell is when it was filed.
| Revenue from operations | 3,785.00 |
| Other income | 28.00 |
| Total income | 3,812.00 |
| Cost of materials consumed | 1,304.00 |
| Purchases of stock-in-trade | 517.00 |
| Changes in inventories | 56.00 |
| Employee benefit expense | 335.00 |
| Finance costs | 41.00 |
Ownership — 2026-06-30, and the change from 2026-03-31
| Holder | Per cent | Change |
|---|---|---|
| promoter and promoter group | 0.67 | 0.00 |
| institutions foreign | 0.04 | -0.00 |
| institutions domestic | 0.08 | -0.00 |
| mutual funds | 0.01 | 0.00 |
| public | 0.33 | 0.00 |
Documents on file
| Class | Most recent | On file |
|---|---|---|
| TRANSCRIPT | 2026-06-30 | 17 |
Financial statements
Filed results, consolidated, in INR crore except per-share figures. Every figure opens to the filing it was read from. Quarterly and annual columns are the periods the filing itself names, never a document date.
Quarterly results, as filed
| Line | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 2,875.00 | 3,384.00 | 2,849.00 | 2,937.00 | 2,825.00 | 3,138.00 | 2,531.00 | 3,073.00 | 3,130.00 | 3,519.00 | 3,019.00 | 3,455.00 | 3,432.00 | 4,003.00 | 3,373.00 | 3,785.00 |
| Other income | 32.00 | 33.00 | 26.00 | 17.00 | 22.00 | 35.00 | 24.00 | 26.00 | 54.00 | 41.00 | 21.00 | 22.00 | 99.00 | 29.00 | 47.00 | 28.00 |
| Total income | 2,908.00 | 3,417.00 | 2,874.00 | 2,955.00 | 2,847.00 | 3,173.00 | 2,555.00 | 3,099.00 | 3,184.00 | 3,560.00 | 3,041.00 | 3,477.00 | 3,531.00 | 4,032.00 | 3,420.00 | 3,812.00 |
| Cost of materials consumed | 778.00 | 1,454.00 | 1,785.00 | 1,056.00 | 750.00 | 1,545.00 | 1,926.00 | 950.00 | 835.00 | 1,731.00 | 1,845.00 | 1,087.00 | 955.00 | 1,899.00 | 1,925.00 | 1,304.00 |
| Purchases of stock-in-trade | 221.00 | 302.00 | 118.00 | 243.00 | 175.00 | 339.00 | 89.00 | 298.00 | 229.00 | 349.00 | 68.00 | 416.00 | 243.00 | 338.00 | 89.00 | 517.00 |
| Changes in inventories | 452.00 | -149.00 | -670.00 | 249.00 | 639.00 | -300.00 | -905.00 | 354.00 | 622.00 | -385.00 | -605.00 | 198.00 | 564.00 | -249.00 | -467.00 | 56.00 |
| Employee benefit expense | 221.00 | 225.00 | 231.00 | 243.00 | 244.00 | 258.00 | 239.00 | 261.00 | 262.00 | 265.00 | 282.00 | 318.00 | 306.00 | 318.00 | 318.00 | 335.00 |
| Finance costs | 11.00 | 13.00 | 12.00 | 25.00 | 15.00 | 15.00 | 32.00 | 29.00 | 38.00 | 43.00 | 43.00 | 44.00 | 43.00 | 49.00 | 40.00 | 41.00 |
| Depreciation and amortisation | 63.00 | 66.00 | 71.00 | 72.00 | 74.00 | 77.00 | 80.00 | 86.00 | 101.00 | 109.00 | 114.00 | 112.00 | 119.00 | 134.00 | 138.00 | 128.00 |
| Other expenses | 933.00 | 997.00 | 1,039.00 | 980.00 | 903.00 | 850.00 | 918.00 | 963.00 | 1,001.00 | 1,064.00 | 1,025.00 | 1,132.00 | 1,055.00 | 1,165.00 | 1,155.00 | 1,236.00 |
| Total expenses | 2,680.00 | 2,908.00 | 2,585.00 | 2,869.00 | 2,800.00 | 2,784.00 | 2,379.00 | 2,941.00 | 3,088.00 | 3,174.00 | 2,771.00 | 3,307.00 | 3,285.00 | 3,654.00 | 3,197.00 | 3,618.00 |
| Profit before exceptional items and tax | 228.00 | 509.00 | 289.00 | 86.00 | 47.00 | 389.00 | 177.00 | 158.00 | 96.00 | 386.00 | 270.00 | 170.00 | 246.00 | 377.00 | 222.00 | 195.00 |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -55.00 | 32.00 | 79.00 |
| Profit before tax | 228.00 | 509.00 | 289.00 | 86.00 | 47.00 | 389.00 | 177.00 | 158.00 | 96.00 | 386.00 | 270.00 | 170.00 | 246.00 | 322.00 | 254.00 | 274.00 |
| Current tax | 50.00 | 91.00 | 47.00 | 15.00 | 9.00 | 78.00 | 96.00 | 28.00 | 17.00 | 69.00 | 47.00 | 31.00 | 49.00 | 58.00 | 55.00 | -59.00 |
| Deferred tax | 50.00 | 76.00 | 55.00 | 14.00 | 6.00 | 71.00 | -37.00 | 30.00 | 16.00 | 54.00 | 43.00 | 25.00 | 38.00 | 52.00 | -172.00 | -359.00 |
| Tax expense | 100.00 | 167.00 | 103.00 | 29.00 | 15.00 | 148.00 | 59.00 | 58.00 | 33.00 | 123.00 | 91.00 | 56.00 | 87.00 | 110.00 | -117.00 | -418.00 |
| Profit for the period | 128.00 | 342.00 | 187.00 | 57.00 | 32.00 | 240.00 | 118.00 | 100.00 | 63.00 | 262.00 | 179.00 | 114.00 | 159.00 | 213.00 | 371.00 | 693.00 |
| Profit attributable to owners | 0.00 | 0.00 | — | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | 113.00 | 158.00 | 212.00 | 370.00 | 0.00 |
| Profit attributable to non-controlling interests | 0.00 | 0.00 | — | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 1.00 | 1.00 | 1.00 | 0.00 |
| Other comprehensive income | 3.00 | 16.00 | 5.00 | -2.00 | -2.00 | 1.00 | -6.00 | -6.00 | 3.00 | -2.00 | -1.00 | 1.00 | 1.00 | -0.00 | 3.00 | -2.00 |
| Total comprehensive income | 131.00 | 358.00 | 191.00 | 55.00 | 31.00 | 242.00 | 112.00 | 95.00 | 66.00 | 260.00 | 178.00 | 115.00 | 160.00 | 212.00 | 373.00 | 691.00 |
| Earnings per share, basic | 8.22 | 21.94 | 11.97 | 3.63 | 2.07 | 15.42 | 7.55 | 6.43 | 4.04 | 16.81 | 11.47 | 7.27 | 10.14 | 13.59 | 23.71 | 44.72 |
| Earnings per share, diluted | 8.22 | 21.94 | 11.97 | 3.63 | 2.07 | 15.42 | 7.55 | 6.43 | 4.04 | 16.81 | 11.47 | 7.27 | 10.14 | 13.59 | 23.71 | 44.42 |
Annual results, as filed
| Line | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 7,771.00 | 7,767.00 | 8,308.00 | 9,849.00 | 12,080.00 | 11,431.00 | 12,741.00 | 14,264.00 |
| Other income | 88.00 | 102.00 | 92.00 | 92.00 | 120.00 | 99.00 | 142.00 | 196.00 |
| Total income | 7,859.00 | 7,870.00 | 8,400.00 | 9,941.00 | 12,199.00 | 11,530.00 | 12,883.00 | 14,460.00 |
| Cost of materials consumed | 3,228.00 | 3,307.00 | 3,345.00 | 3,956.00 | 4,784.00 | 5,276.00 | 5,360.00 | 5,867.00 |
| Purchases of stock-in-trade | 771.00 | 730.00 | 810.00 | 857.00 | 890.00 | 845.00 | 943.00 | 1,086.00 |
| Changes in inventories | -308.00 | -222.00 | 371.00 | -377.00 | 0.00 | -316.00 | -15.00 | 46.00 |
| Employee benefit expense | 664.00 | 736.00 | 733.00 | 783.00 | 891.00 | 984.00 | 1,070.00 | 1,260.00 |
| Finance costs | 119.00 | 164.00 | 122.00 | 85.00 | 53.00 | 88.00 | 153.00 | 176.00 |
| Depreciation and amortisation | 157.00 | 219.00 | 233.00 | 238.00 | 260.00 | 303.00 | 410.00 | 502.00 |
| Other expenses | 2,047.00 | 2,024.00 | 1,898.00 | 2,834.00 | 3,908.00 | 3,651.00 | 4,053.00 | 4,508.00 |
| Total expenses | 6,679.00 | 6,958.00 | 7,511.00 | 8,376.00 | 10,786.00 | 10,831.00 | 11,974.00 | 13,445.00 |
| Profit before exceptional items and tax | 1,180.00 | 912.00 | 889.00 | 1,565.00 | 1,413.00 | 699.00 | 909.00 | 1,016.00 |
| Exceptional items | 0.00 | -15.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -23.00 |
| Profit before tax | 1,180.00 | 897.00 | 889.00 | 1,565.00 | 1,413.00 | 699.00 | 909.00 | 992.00 |
| Current tax | 251.00 | 106.00 | 167.00 | 484.00 | 257.00 | 198.00 | 162.00 | 194.00 |
| Deferred tax | 27.00 | 72.00 | 50.00 | 14.00 | 245.00 | 54.00 | 143.00 | -57.00 |
| Tax expense | 278.00 | 178.00 | 217.00 | 499.00 | 502.00 | 252.00 | 305.00 | 136.00 |
| Profit for the period | 904.00 | 722.00 | 674.00 | 1,067.00 | 911.00 | 447.00 | 604.00 | 856.00 |
| Profit attributable to owners | — | — | — | — | — | — | — | 853.00 |
| Profit attributable to non-controlling interests | — | — | — | — | — | — | — | 3.00 |
| Other comprehensive income | 0.00 | -12.00 | 4.00 | -19.00 | 13.00 | -8.00 | -6.00 | 4.00 |
| Total comprehensive income | 904.00 | 710.00 | 678.00 | 1,048.00 | 924.00 | 439.00 | 599.00 | 860.00 |
| Earnings per share, basic | 57.09 | 45.96 | 43.17 | 68.45 | 58.41 | 28.67 | 38.75 | 54.73 |
| Earnings per share, diluted | 57.09 | 45.96 | 43.17 | 68.45 | 58.41 | 28.67 | 38.75 | 54.73 |
Balance sheet, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 9,760.00 | 10,722.00 | 10,981.00 | 11,549.00 | 12,101.00 | 12,732.00 | 13,221.00 | 14,137.00 |
| Non-current assets | 5,047.00 | 6,013.00 | 6,662.00 | 7,075.00 | 7,520.00 | 7,619.00 | 8,103.00 | 8,555.00 |
| Current assets | 4,685.00 | 4,686.00 | 4,303.00 | 4,460.00 | 4,567.00 | 5,093.00 | 5,103.00 | 5,564.00 |
| Property, plant and equipment | 3,377.00 | 4,012.00 | 4,004.00 | 4,130.00 | 5,859.00 | 6,426.00 | 6,761.00 | 7,359.00 |
| Capital work-in-progress | 1,120.00 | 1,618.00 | 2,358.00 | 2,597.00 | 1,188.00 | 805.00 | 821.00 | 532.00 |
| Goodwill | 81.00 | 81.00 | 81.00 | 81.00 | 81.00 | 81.00 | 106.00 | 139.00 |
| Other intangible assets | 10.00 | 12.00 | 10.00 | 10.00 | 9.00 | 10.00 | 18.00 | 19.00 |
| Inventories | 1,461.00 | 2,376.00 | 1,416.00 | 2,677.00 | 1,621.00 | 2,799.00 | 2,143.00 | 3,108.00 |
| Trade receivables | 1,276.00 | 869.00 | 645.00 | 646.00 | 706.00 | 919.00 | 1,049.00 | 1,081.00 |
| Cash and cash equivalents | 846.00 | 450.00 | 1,281.00 | 343.00 | 1,125.00 | 620.00 | 832.00 | 306.00 |
| Total equity and liabilities | 9,760.00 | 10,722.00 | 10,981.00 | 11,549.00 | 12,101.00 | 12,732.00 | 13,221.00 | 14,137.00 |
| Equity | 5,800.00 | 6,194.00 | 6,224.00 | 6,522.00 | 6,642.00 | 7,004.00 | 7,244.00 | 7,733.00 |
| Equity share capital | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 |
| Other equity | 5,769.00 | 6,162.00 | 6,193.00 | 6,491.00 | 6,611.00 | 6,973.00 | 7,194.00 | 7,681.00 |
| Total liabilities | 3,960.00 | 4,528.00 | 4,756.00 | 5,027.00 | 5,458.00 | 5,728.00 | 5,976.00 | 6,404.00 |
| Non-current liabilities | 1,753.00 | 1,962.00 | 2,092.00 | 2,261.00 | 2,362.00 | 2,485.00 | 2,449.00 | 2,669.00 |
| Current liabilities | 2,190.00 | 2,550.00 | 2,654.00 | 2,758.00 | 3,088.00 | 3,237.00 | 3,520.00 | 3,725.00 |
| Borrowings, non-current | 1,090.00 | 1,154.00 | 1,265.00 | 1,385.00 | 1,431.00 | 1,391.00 | 1,272.00 | 1,601.00 |
| Borrowings, current | 381.00 | 479.00 | 208.00 | 698.00 | 704.00 | 1,017.00 | 790.00 | 1,211.00 |
| Trade payables | 800.00 | 1,011.00 | 946.00 | 1,040.00 | 1,167.00 | 1,185.00 | 1,276.00 | 1,218.00 |
Cash flow, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | 942.00 | 1,296.00 | 1,807.00 | 794.00 | 1,735.00 | 1,128.00 | 1,524.00 | 1,234.00 |
| Net cash from investing activities | -870.00 | -1,543.00 | -683.00 | -1,070.00 | -868.00 | -850.00 | -470.00 | -1,241.00 |
| Net cash from financing activities | -157.00 | -235.00 | -293.00 | 169.00 | -85.00 | -1.00 | -842.00 | -307.00 |
| Purchase of property, plant and equipment | 932.00 | 1,797.00 | 792.00 | 1,310.00 | 504.00 | 845.00 | 352.00 | 869.00 |
| Net increase in cash | -85.00 | -482.00 | 831.00 | -107.00 | 782.00 | 277.00 | 212.00 | -314.00 |
| con:CFO.BEFORE_TAX | 1,065.00 | 1,625.00 | 1,861.00 | 990.00 | 1,796.00 | 1,225.00 | 1,621.00 | 1,322.00 |
| con:INTEREST_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INTEREST_PAID.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:DIVIDENDS_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:TAX_PAID.OPERATING | 123.00 | 328.00 | 54.00 | 196.00 | 61.00 | 97.00 | 97.00 | 88.00 |
| con:CF_OTHER.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INVESTMENTS_PURCHASED | 0.00 | 9.00 | 41.00 | 41.00 | 0.00 | 2.00 | 17.00 | 17.00 |
| con:INVESTMENTS_SOLD | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:PPE_DISPOSALS | 31.00 | 45.00 | 8.00 | 13.00 | 9.00 | 13.00 | 10.00 | 17.00 |
| con:CF_INVESTING.SUBSIDIARIES_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.SUBSIDIARIES_ACQUIRED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 78.00 | 78.00 |
| con:CF_INVESTING.JV_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_ACQUIRED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Who owns it
The shareholding pattern filed with the exchange every quarter, as a series. Percentages are of total shares. Each figure names the filing it was read from and the date it was filed.
| Holder | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter and promoter group | 66.52 | 66.52 | 66.52 | 66.52 | 66.52 | 66.52 | 66.52 | 66.52 | 66.52 | 66.52 | 0.67 | 0.67 | 0.67 | 0.67 |
| Domestic institutions | 8.85 | 8.70 | 8.53 | 8.40 | 8.10 | 8.07 | 7.67 | 7.65 | 7.76 | 8.05 | 0.08 | 0.08 | 0.09 | 0.08 |
| Mutual funds | — | — | — | — | — | — | — | — | — | 0.68 | 0.01 | 0.01 | 0.01 | 0.01 |
| Insurance companies | 7.38 | 7.35 | 7.42 | 7.41 | 7.41 | 7.41 | 6.85 | 6.85 | 6.86 | 6.86 | 0.07 | 0.07 | 0.07 | 0.07 |
| Foreign institutions | 2.67 | 2.59 | 2.86 | 3.41 | 3.75 | 3.74 | 3.78 | 4.00 | 4.10 | 4.13 | 0.04 | 0.04 | 0.04 | 0.04 |
| Government | — | — | — | — | — | — | — | — | — | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 32.46 | 32.52 | 32.56 | 32.54 | 32.56 | 32.60 | 32.76 | 32.77 | 32.69 | 32.72 | 0.33 | 0.33 | 0.33 | 0.33 |
| Non-institutional | 20.93 | 21.21 | 21.14 | 20.72 | 20.69 | 20.77 | 21.28 | 21.11 | 20.81 | 20.52 | 0.21 | 0.20 | 0.20 | 0.20 |
| Shares outstanding | 155942296 | 155942296 | 155942296 | 155942296 | 155942296 | 155942296 | 155942296 | 155942296 | 155942296 | 155942296 | 155942296 | 155942296 | 155942296 | 155942296 |
Related parties
Transactions with related parties as disclosed to the exchange for the period ending 2024-09-30, by counterparty, largest first. Amounts are as filed. Each row names the filing and the date it was filed.
| Counterparty | Relationship | Type | Amount in the period | Transactions |
|---|---|---|---|---|
| Shriram Agsmart Limited | Subsidiary | Purchase of goods or services, Sale of goods or serv | 281,800,000.00 | 2 |
| Shriram Polytech Limited | Subsidiary | Sale of goods or services | 260,200,000.00 | 1 |
| Renew Green (GJ Ten) Private Limited | Associate | Purchase of goods or services | 210,800,000.00 | 1 |
| Renew Green (GJ Nine) Private Limited | Associate | Purchase of goods or services | 140,100,000.00 | 1 |
| Mr. Vikram S. Shriram | Vice Chairman and Managing Directo | Remuneration | 109,500,000.00 | 1 |
| Mr. Ajay S. Shriram | Chairman and Senior Managing Direc | Remuneration | 109,300,000.00 | 1 |
| Bioseed Research Philippines Limited | Subsidiary | Sale of goods or services | 109,000,000.00 | 1 |
| Mr. Ajit S. Shriram | Joint Managing Director | Remuneration | 102,600,000.00 | 1 |
| DCM Shriram Foundation | Subsidiary | Any other transaction | 83,700,000.00 | 1 |
| DCM Shriram Bio Enchem Limited | Subsidiary | Any other transaction, Purchase of goods or services | 38,800,000.00 | 3 |
| Fenesta India Limited | Subsidiary | Advance, Sale of goods or services | 29,800,000.00 | 2 |
| Mr. Aditya A. Shriram | Deputy Managing Director | Remuneration | 16,400,000.00 | 1 |
| Ajay S. Shriram (HUF) | Promoter | Any other transaction | 6,900,000.00 | 2 |
| Mr. Anand Shriram | Promoter | Remuneration | 5,700,000.00 | 1 |
| Mr. Pranav Shriram | Promoter | Remuneration | 3,600,000.00 | 1 |
What management said
Every earnings call we hold for this company, read in full. Prepared remarks are separated from the question-and-answer session and every paragraph names who said it and on which page. These are management’s own words, not filed figures.
| Date | Quarter | Who spoke | |
|---|---|---|---|
| 2026-08-05 | Q1FY27 | Read the call | |
| 2026-05-21 | Q4FY26 | Read the call | |
| 2026-01-29 | Q3FY26 | Read the call | |
| 2025-11-06 | Q2FY26 | Read the call | |
| 2025-07-29 | Q1FY26 | Read the call | |
| 2025-05-14 | Q4FY25 | Read the call | |
| 2025-01-27 | Q3FY25 | Read the call | |
| 2024-11-11 | Q2FY25 | Read the call | |
| 2024-07-31 | Q1FY25 | Read the call | |
| 2024-05-13 | Q4FY24 | Read the call | |
| 2024-02-08 | Q3FY24 | Read the call | |
| 2023-11-08 | Q2FY24 | Read the call | |
| 2023-08-02 | Q1FY24 | Read the call | |
| 2023-05-12 | Q4FY23 | Read the call | |
| 2022-10-25 | Q2FY23 | Read the call | |
| 2022-07-30 | Q1FY23 | Read the call | |
| 2022-05-13 | Q4FY22 | Read the call |
What they said about it, quarter by quarter
| Topic | Q3FY24 | Q3FY25 | Q3FY26 | Q4FY22 | Q4FY23 | Q4FY24 | Q4FY25 | Q4FY26 |
|---|---|---|---|---|---|---|---|---|
| Capex | What would be the payback period for our CAPEX? | So, the new plant, what would be the capacity utilizations like? | PBDIT was down by 8% due to higher fixed costs given business growth & stabilization costs of new plants, partly offset by lower input prices and bett… | My first question is regarding the CAPEX part. | With healthy cash flows across our businesses, our debt levels remained at comfortable levels despite the continuing CAPEX. | Aluminium will be the other segment where India is seeing capacity additions. | Sir, my questions are in terms of CAPEX, how do you see the CAPEX in terms of amount for this year and next year? | The Board, as you would know, has approved a capex of INR101 crore in its Board meeting 2 days ago to enhance the formulated resin capacity from what … |
| Capital allocation | Yes it depends on case-to-case, but it can take up to 3 years also depending on land acquisition, environment clearance and then executions. | — | Our nation’s trajectory—powered by a massive infrastructure build-up and a demographic dividend that is actively converting into consumption and entre… | — | The Board has recommended a final dividend of 180%, amounting to Rs. | — | On Epoxy and Advanced Materials, we have completed the land acquisition. | On the Fenesta margins, is there any impact on margins because of the acquisition of DNV, if you can quantify the number? |
| Costs | So, how much of cost saving will come from this one. | Where would we see cost saving coming in the chemicals division as such? | — | Are we facing any input cost pressures this segment as well? | Margins were moderated by higher input cost. | — | — | So the margins will depend again on how the raw material prices and how the finished good prices move. |
| Debt and cash | So, this net debt figure of 314 on December end not likely to go up much from here? | — | The company’s net debt is at Rs 1,084 crores as on 31st December, 2025 as against Rs 867 crores as on 31st December, and Rs 1,395 crore s as on 31st M… | So, just to have an understanding on the thought process, what kind of working capital requirement is required to run the business on an annual basis … | Our net debt as on 31st March 2023 is Rs. | So the current cost of debt blended short term, long term is around 7.5% and see debt level will be governed by the cash flows and the next year plan. | — | — |
| Demand | So, wanted to know what is the demand supply scenario and would that lead to any oversupply in the industry? | We have seen that the caustic price has been stable and has gone up, but of course the pressure on chlorine continues due to the capacity and the dema… | While demand is strong in regions like Asia-Pacific, the industry is also facing challenges like fluctuating prices due to economic factors, geopoliti… | So, how does the India demand supply dynamics play by with so much of capacity and how do we see ensuring our returns on ECH? | In view of the rising demand this year we commissioned our Bhuvneshwar factory and added one more factory in Hyderabad. | And so they consume pipeline chlorine from us, and that's been the backbone for us. | So on the PVC side, so just wanted to understand on a brief part that we know there is subdued demand, as well as dumping from Chinese guys out there. | So as we mentioned earlier in the call as well, the global caustic capacity is close to 109 million metric tons and of course the demand is spread acr… |
| Guidance | But we expect that with our chlorine integration as well that we are focusing on, that this capacity will get absorbed and running fully in the next f… | So, we do expect it to take a little time, but we expect that in the next 12 to 18 months we will reach full capacity utilization. | And any kind of guidance before I -- like I end my questions, any kind of guidance on the top line or bottom line for the next say 2 years down the li… | So, just wanted to understand, are we expecting our new additional aluminum chloride capacity to come up in this quarter itself? | The product basket of research activity is being rationalized and we expect the business to do better in the coming year. | So that a large part of the chlorine will also be consumed along with our pipeline customers and over time we expect the market to grow steadily as we… | But we expect that the kind of balance sheet maintenance would be one of the pivotal ways you look at growing your business? | So one is that when do we expect the MIP to come in place because it has been since a while that the PVC ADD is now out of question? |
| Margin | — | Unless something happens on the cost front, the margin of 19% are quite reasonable. | And we have also seen this margin pressure continuing for the Fenesta vertical right and last quarter also you had mentioned that it was primarily bec… | Just one question on Fenesta, do we have any margin differential for project segment versus retail segment? | So, I want to know the demand scenario as well as the margin impact for the quarter, why the margin is lower with the lower raw material price? | So still as we mentioned that we would like to maintain our debt-to-EBITDA level that's what our financial prudence principle is, it should be in the … | Yes, we would like to maintain the balance between balance sheet strength and leverage and debt and EBITDA. | And also in terms of margin profile at current prices with the full value chain, glycerine and so on, what sort of margin profile one should consider … |
| People | So, we do expect that it will take some time for our capacity utilization, therefore, to ramp up. | As I mentioned in my opening remarks, the capacity utilization in the complex at Bharuch is in the range of about 70%. | First is the Chemicals Business Globally, caustic soda market is operating at around 80% utilization, with world-wide annual installed capacity of app… | If you look at our volumes, we were a little higher on overall volume by about 15,000 tons more than what we did in Q3 because our utilization levels … | Overall, capacity utilization was lower at 91% versus 96% last year. | So if you can just walk us through in terms of what are the feedbacks you are receiving from the customers in terms of improvement in their existing c… | Sir, what could be the utilization levels of the newly commissioned 120 megawatt power plant? | So you are right that some particular utilization in the Middle East has reduced, but we have to see how it all plays out. |
| Pricing | That opens up another avenue of selling our products, if the pricing is suitable. | So, I would say these are reasonable margins at a price realization for PVC at about Rs. | PVC pricing continued to witness downward pressure given abundant imports and global oversupply. | Q3 to Q4 price increase would be more or less the same, about 4%-5% increase and if I look at my cost, actually costs have actually come down a little… | Transfer price I think one should look at overall, if you have sugar as a business, every business every company might have their own transfer pricing… | That has an implication on the pricing in the Western market which has been associated with that. | And sir, we have seen uptick in for Caustic Soda in November, December, there was some bit of a price realization in Jan and Feb and then again, it wa… | So just want to understand the broad aspects on the pricing what we should expect going forward. |
| Revenue growth | And secondly, could you just share some details on your agri business because I think your agri has done exceptionally well in a kind of a challenging… | Sir, we have an order book growth of 33%, last quarter also we had order book growth, but it's not translating into revenue growth. | Shriram Farm Solutions The SFS business sustained momentum, delivering healthy revenue growth. | — | Fenesta Building Systems revenue reported a growth of 13% year-on-year and PBDIT was stable. | So if I got your question right, you're saying the growth of aluminium versus UPVC, have I understood it right? | But then it would be followed by an increase in topline and bottom-line in the following years. | — |